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Association of Prediagnostic Serum Vitamin D Levels
with the Development of Basal Cell Carcinoma
Maryam M. Asgari1,2, Jean Tang3, Margaret E. Warton1, Mary-Margaret Chren2,4, Charles P. Quesenberry Jr1,
Dan Bikle2, Ronald L. Horst5, Norman Orentreich6, Joseph H. Vogelman6 and Gary D. Friedman1,7
We investigated the association between serum 25-hydroxyvitamin D (25(OH)D) levels and basal cell carcinoma
(BCC) risk in a nested case–control study at Kaiser Permanente Northern California (KPNC). A total of 220 case
patients with BCC diagnosed after serum collection were matched to 220 control subjects. We estimated odds
ratios (ORs) and 95% confidence intervals (CIs) using conditional logistic regression. Fully adjusted models
included body mass index (BMI), smoking, education, sun-exposure variables, X-ray exposure, and personal
history of cancer. For each measure of serum 25(OH)D (continuous, clinically relevant tertiles, quintiles), we
found an increased risk of BCC in unadjusted models (OR¼ 1.03, 95% CI 1.00–1.05, Po0.05; OR¼ 3.98, 95% CI:
1.31–12.31, deficient vs. sufficient, test for trend P-value o0.01; OR¼ 2.32, 95% CI: 1.20–4.50, 1st vs. 5th quintile,
test for trend P-value 0.03). In fully adjusted models, the values attenuated slightly (OR¼ 1.02, 95% CI 1.00–1.05,
Po0.05; OR¼ 3.61, 95% CI: 1.00–13.10, deficient vs. sufficient, t-trend P¼ 0.03; OR¼ 2.09 1st vs. 5th quintile, 95%
CI: 0.95–4.58, t-trend P¼ 0.11). Our findings suggest that higher prediagnostic serum 25(OH)D levels may be
associated with increased risk of subsequent BCC. Further studies to evaluate the effect of sun exposure on
BCC and serum 25(OH)D levels may be warranted.
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INTRODUCTION
Basal cell carcinoma (BCC) is the most common cancer in the
United States affecting nearly one million Americans
annually (Jemal et al, 2009) and its incidence is rising (Miller
and Weinstock, 1994; Christenson et al, 2005). Although
BCCs are rarely fatal, their high incidence and the frequent
occurrence of new primary BCCs in affected individuals
(Karagas et al, 1992) can cause significant morbidity. BCCs
also pose a substantial financial impact and are among the
most costly cancers to treat in the Medicare population
(Housman et al, 2003). The main known risk factors for BCC
are sun sensitivity and exposure to ultraviolet (UV) radiation.
The same spectrum of UV radiation (280–320 nm) causes
both DNA damage to keratinocytes and vitamin D synthesis
by these cells (Freeman et al, 1989). This has led some
investigators to propose that vitamin D formation in
keratinocytes may be an innate protective mechanism against
UV damage (Bikle, 2008).
Recent studies have shown that vitamin D can regulate
differentiation of normal skin cells (Bikle, 2004) and can
reduce hedgehog signaling in and proliferation of murine
BCC cell lines (Xiao et al, 2009). In mice, vitamin D receptor
knockouts are more susceptible to chemically induced and
UVR-induced skin tumors, suggesting that disruption of
vitamin D receptor signaling predisposes to skin cancer
(Zinser et al, 2002). Vitamin D receptor polymorphisms have
been associated with increased BCC risk (Ramachandran
et al. 2003). Immunohistochemical studies of human BCCs
suggest that the vitamin D pathway may be important for the
growth behavior of BCCs (Kamradt et al, 2003; Mitschele
et al, 2004). Despite mounting evidence that vitamin D and
its receptor are involved in cutaneous carcinogenesis, no
studies to date have examined the association of serum
vitamin D levels with BCC risk in humans.
The epidemiology of BCCs has been difficult to character-
ize because most cancer registries, such as the Surveillance,
Epidemiology, and End Results program exclude non-
melanoma skin cancers. However, the Kaiser Permanente
Northern California (KPNC) setting includes electronic
databases that capture information on all pathology speci-
mens received for examination, allowing for accurate
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recording of BCC. Using an established cohort of KPNC
members with data on self-reported cancer risk factors and
prediagnostic serum vitamin D levels, we performed a nested
case–control analysis to study the association between
prediagnostic serum vitamin D levels and subsequent
BCC risk.
RESULTS
The 440 study participants included 228 men and 212
women with a mean age of 54.9 years (SD 10.1, range
28–78). The mean years to BCC among cases was 8.74 years
(SD 1.28, min¼6.14, max¼ 11.33). Cases were more likely
than controls to report a personal history of cancer and
slightly more likely than control subjects to have lower BMI
and to have never smoked (Table 1). Cases and controls did
not differ with regard to education, any of the sun exposure
variables, or history of X-ray exposure. Serum 25(OH)D
levels were slightly higher among the cases than among the
controls.
The mean 25(OH)D concentration in all study subjects did
not differ by baseline characteristics including age at cohort
entry, eye color, occupational sun exposure, time spent in
leisure activities, smoking status, personal history of cancer,
or history of X-ray exposure (Table 2). Subjects with higher
25(OH)D levels were more likely to be male, more educated,
and to report no exposure to occupational UV 1 year before
taking the Multiphasic Health Checkup (MHC). Those who
exercised 2–4 h per day had higher levels than those who
exercised less (0–1 h day–1) whereas obese patients (BMI
X30 kgm–2) had lower 25(OH)D levels compared with
non-obese patients (BMI o25).
In the unadjusted model, a positive association was noted
between higher 25(OH)D levels and increased BCC risk
whether assessing 25(OH)D as a continuous variable, a
categorical variable based on clinical cutoffs, or a categorical
variable based on the distribution of 25(OH)D levels among
controls divided into quintiles (Table 3). For every 1 ngml–1
rise in serum 25(OH)D levels, there was a 3% increase in
BCC risk. An added quadratic term for continuous 25(OH)D
levels in the unadjusted model was not significant, indicating
that a linear model better approximated the relationship
between 25(OH)D and BCC risk (data not shown). Indivi-
duals who had clinically sufficient 25(OH)D levels
(X30 ngml–1) were at increased risk of BCC compared with
those who were 25(OH)D deficient (o10 ngml–1). Similarly,
those in the highest quintile had increased risk compared
with those in the lowest quintile.
The results did not substantially change when analyzed
using the parsimonious model (model 1) or the fully adjusted
model (model 2). In both models, each 1 ngml–1 increase in
serum 25(OH)D levels was associated with a corresponding
2% rise in BCC risk (Po0.05). Subjects with sufficient
25(OH)D levels were still at increased risk of BCC compared
to those with deficient levels using the parsimonious and fully
adjusted models. The association between serum 25(OH)D
divided into quintiles and BCC risk was significant in the
parsimonious model (P¼ 0.05, test for trend). Risk estimates
in the fully adjusted model using quintiles were slightly
Table 1. Selected characteristics of BCC case and
control subjects nested within the KPNC Multiphasic
Health Checkup cohort
Characteristic
BCC
n=220
Control
n=2201 P-value2
Demographic
Education, n (%)
High school or less 94 (42.7) 105 (47.7)
Any college 126 (57.3) 115 (52.3) 0.29
Sun exposure surrogate variables
Occupational UV (self-reported), n (%)
No 212 (96.4) 214 (97.3) 0.76
Yes 6 (2.7) 5 (2.3)
Occupational sun (assigned), n (%)
High 7 (3.2) 6 (2.7) 0.96
Moderate 118 (53.6) 119 (54.1)
Low 95 (43.2) 95 (43.2)
Leisure time activities
(no. of hours/day), n (%)3
0–1 27 (12.3) 25 (11.4) 0.90
2–4 151 (68.6) 153 (69.6)
45 26 (11.8) 29 (13.2)
Missing 16 (7.3) 13 (5.9)
Exercise (no. of hours/day), n (%)4
0–1 140 (63.6) 138 (63.7) 0.96
2–4 55 (25.0) 59 (26.8)
45 11 (5.0) 11 (5.0)
Missing 14 (6.4) 12 (5.5)
Other variables
BMI (kgm–2), mean (SD) 24.9 (3.3) 25.5 (3.7) 0.07
Smoking status (cigarettes), n (%)
Never 103 (46.8) 86 (39.1) 0.17
Former 49 (22.3) 61 (27.7)
Current 57 (25.9) 54 (24.6)
Missing 11 (5.0) 19 (8.6)
Personal history of cancer, n (%)
No 169 (76.8) 200 (90.9)
Yes 44 (20.0) 12 (5.5) o0.001
Missing 7 (3.2) 8 (3.6)
X-ray exposure, n (%)
No 212 (96.4) 215 (97.7) 0.40
Yes 8 (3.64) 5 (2.3)
Serum 25(OH)D, mean (SD), ngml–1 25.5 (11.4) 23.3 (10.1) 0.03
1Controls individually matched by age (±1 years), skin color (white), eye
color, sex, date of serum collection (±1 month to control for seasonality),
Multiphasic location and length of KPNC membership.
2P-values are derived from w2-test for categorical and t-test for continuous
variables.
3Defined as ‘‘hobby, TV, etc.’’
4Defined as ‘‘walking, sports, etc.’’
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attenuated, bordering on statistical significance (P¼ 0.11, test
for trend).
DISCUSSION
The findings from this nested case–control study suggest that
higher prediagnostic serum 25(OH)D levels may be asso-
ciated with increased risk of subsequent BCC. For every
1 ngml–1 increase in serum 25(OH)D levels, there was a
corresponding 2% increased adjusted risk of BCC. Our data
do not support in vitro evidence which suggests that vitamin D
may inhibit BCC cell growth (Xiao et al, 2009). However,
that growth is inhibited by vitamin D3, and our measure-
ments were of 25(OH)D, which is ineffective in the in vitro
assays. To our knowledge, there have been no published
papers comparing serum 25(OH)D levels in a population-
based sample of individuals with BCC to controls.
UV exposure is a known risk factor for BCCs and is the
most readily available source of vitamin D in sunny climates,
such as that in the San Francisco Bay Area. A possible expla-
nation of our finding is that the carcinogenic effects of the
amount of UV exposure that leads to high serum 25(OH)D
levels may overwhelm any possible protective effect of
vitamin D noted in vitro. In addition, residual confounding by
Table 2. Mean serum 25-hydroxyvitamin D according
to subject characteristics
Characteristic n
Mean
25(OH)D (SD) P-value1
Demographics
Age in years (at study entry)
28–44 78 25.1 (12.1) 0.31
45–54 129 25.6 (10.3)
55–64 156 23.7 (10.5)
X 65 77 23.2 (10.7)
Gender
Male 228 26.3 (10.4) o0.001
Female 212 22.4 (10.9)
Eye color
Brown 74 23.2 (8.4) 0.30
Green/Gray 24 27.7 (7.9)
Blue 216 24.2 (11.0)
Other 126 24.8 (12.2)
Education (years)
High school or less 199 22.7 (10.1) o0.01
Any college 241 25.8 (11.2)
Sun exposure surrogate variables
Occupational UV (self-reported)
No 429 24.6 (10.8) 0.07
Yes 11 18.6 (7.6)
Occupational sun (assigned)
High 13 27.0 (7.8) 0.68
Moderate 237 24.2 (11.1)
Low 190 24.5 (10.6)
Leisure time activities
(no. of hours/day)2
0–1 52 25.9 (11.1) 0.24
2–4 304 24.6 (10.8)
X5 55 21.9 (10.4)
Missing 29 24.6 (11.1)
Exercise (no. of hours/day)3
0–1 278 23.3 (10.3) 0.04
2–4 114 26.7 (11.8)
X5 22 25.3 (9.0)
Missing 26 24.7 (11.5)
Table 2. Continued
Characteristic n
Mean
25(OH)D (SD) P-value1
Other variables
Body mass index (kgm-2)
o 25 221 25.9 (12.1)
25–29.9 168 23.7 (9.2) 0.004
X30 31 19.5 (8.5)
Missing 20 21.3 (8.4)
Smoking status (cigarettes)
Never 189 23.8 (9.6) 0.08
Former 110 26.7 (11.1)
Current 111 23.5 (12.5)
Missing 30 23.2 (9.3)
Personal history of cancer
No 369 24.7 (11.0) 0.32
Yes 56 23.8 (9.7)
Missing 15 20.5 (9.8)
X-ray exposure
No 427 24.4 (10.8) 0.71
Yes 13 25.5 (11.3)
1For categorical variables, P-values calculated for evidence of dissimilar
mean values among groups using PROC ANOVA.
2Defined as ‘‘hobby, TV, etc.’’
3Defined as ‘‘walking, sports, etc.’’
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UV exposure is possible in this analysis. We attempted to
control for sun exposure by reasoning that the exposure
would come from two primary sources: time spent in the sun
for leisure and exercise and time spent in the sun related to
one’s occupation. We therefore used occupational UV and
occupational sun exposure as well as time spent in leisure
activities and exercise as surrogate markers for sun exposure.
However, none of our sun exposure surrogate variables was a
significant risk factor for BCC, suggesting that our surrogates
did not adequately capture the type of sun exposure (acute,
intermittent) that has been reported to be associated with
BCC risk (Kricker et al, 1995; Rosso et al, 1998). With the
exception of exercise, the sun exposure surrogate variables
also were not associated with levels of serum 25(OH)D. In
fact, subjects who reported higher occupational UV exposure
paradoxically had lower serum 25(OH)D levels. One expla-
nation for this finding may relate to the way the question
was phrased, which asked subjects to report whether they
worked in a place where they were often or daily exposed to
ultraviolet radiation before 1 year before taking the MHC. UV
exposure in this time period may not have been relevant to
serum 25(OH)D levels over a year later. Also subjects may
not have comprehended that ultraviolet radiation is primarily
derived from the sun. This lack of comprehension is suppor-
ted by the fact that the same individuals who reported in the
affirmative about ‘‘UV exposure’’ did not have occupational
codes that matched high sun-exposure occupations.
Another potential limitation of our study is the length of
storage of the samples. However, these samples have been
used in the past for multiple serum vitamin D metabolite
studies, which have documented levels in the expected normal
range (Corder et al, 1993, 1995; Hiatt et al, 1998). Indeed, our
overall mean serum 25(OH)D level of 24.4 does not differ
substantially from the mean serum 25(OH)D level in the US
population between 1988 and 2004 (24–30ngml–1) as reported
by NHANES (Ginde et al, 2009). Also, any systematic bias in
the storage of the specimens between cases and controls is
unlikely, as cases and controls were matched by serum date.
Attenuation of risk estimates may have been possible if
some control subjects had BCC diagnosed outside of the
KPNC system. All cases and controls were members during
each year of follow-up, and so we believe this is unlikely, as
KPNC is a comprehensive healthcare system and members
would have had to pay out-of-pocket for services received
outside the health plan. It should be noted that the exposures
that we studied were obtained at a single point in time and
were not measured over the entire study follow-up period.
Also, subsequent BCC diagnoses as captured through
pathology records were not necessarily incident cases.
The strength of this study is that vitamin D status was
assessed up to 11 years before the diagnosis of BCC, thereby
reducing the likelihood of reverse causality. Our study also
has internal validity because both cases and controls were
derived from the same prospective cohort. The measurement
of serum 25(OH)D levels reflects internal vitamin D status
and is considered superior to measures of vitamin D
intake by dietary questionnaires alone or predictors of
vitamin D status. It is interesting to note that previous reports
of dietary intake of vitamin D and BCC risk have found no
association (van Dam et al, 2000; Gandini et al, 2009). Also,
Table 3. ORs and 95% CIs for the association between serum 25-hydroxyvitamin D and BCC risk (unadjusted,
parsimonious model, fully adjusted)
Vitamin D
Unadjusted OR
(95% CI)
Model 1 (parsimonious)
OR (95% CI)1
Model 2 (fully adjusted)
OR (95% CI)2
Continuous (ngml–1) 1.03 (1.00, 1.05) 1.02 (1.00, 1.05) 1.02 (1.00, 1.05)
Clinical tertiles (ngml–1)
Deficient (o10) 1.00 (referent) 1.00 (referent) 1.00 (referent)
Insufficient (10–o30) 2.41 (0.86, 6.80) 2.65 (0.89,7.95) 2.30 (0.70, 7.60)
Sufficient (X30) 3.98 (1.31, 12.13) 4.07 (1.26, 13.13) 3.61 (1.00, 13.10)
P-value (trend) o 0.01 0.02 0.03
Quintiles (ngml–1)
1 (o14.70) 1.00 (referent) 1.00 (referent) 1.00 (referent)
2 (14.70–20.06) 1.70 (0.94, 3.09) 1.76 (0.94, 3.33) 1.67 (0.84, 3.34)
3 (20.07–24.67) 1.10 (0.56, 2.13) 1.13 (0.56, 2.30) 1.11 (0.51, 2.43)
4 (24.68–29.78) 1.64 (0.83, 3.24) 1.66 (0.81, 3.40) 1.54 (0.70, 3.37)
5 (429.78) 2.32 (1.20, 4.50) 2.20 (1.10, 4.40) 2.09 (0.95, 4.58)
P-value (trend) 0.03 0.05 0.11
Abbreviations: BCC, basal cell carcinoma; BMI, body mass index; CI, confidence interval; OR, odds ratio.
1Adjusted for smoking status and continuous BMI with imputed values for missing BMI (n=20).
2Adjusted for continuous BMI (with imputed values for n=20 missing), education, sun-exposure surrogates (hours of exercise and leisure activities,
occupational UV, occupational sun exposure level), X-ray exposure, smoking status, and personal history of cancer.
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serum 25(OH)D is a measure of vitamin D levels over the past
several weeks to several months and is a valid measure of
steady-state levels (Holick 1990). Furthermore, to minimize
misclassification of vitamin D status due to seasonal variation,
we matched cases and controls by season of blood draw (±1
month). Finally, men and women with a diverse age range
(28–78 years) were included in the analysis, making our
results more generalizable to whites in the US population.
In summary, we observed an increased BCC risk with
higher prediagnostic serum vitamin D levels. It is likely that
sun exposure, especially acute intermittent exposure, con-
founds this association. Our findings may also have been
influenced by other variables not ascertained in our study,
such as supplemental vitamin D use or healthcare screening
bias. Future studies that can accurately measure acute
intermittent sun exposure, supplemental vitamin D use, and
other potential confounding factors may be warranted.
MATERIALS AND METHODS
Study population
The source population consisted of members of KPNC who had
completed a MHC between August 1968 and January 1970. The
MHC was a voluntary, comprehensive health evaluation that
included a detailed self-administered MHC questionnaire (MHCQ),
a standardized physical examination, and a group of specialty
examinations and laboratory tests administered to a total of 206,974
KPNC members between 1964 and 1973. MHC participants were
instructed to fast overnight before a blood collection that was used
for routine screening. Details about the MHC have been previously
published (Collen and Davis 1969; Cutler et al, 1973) and the cohort
has been used for numerous risk factor studies (Hiatt and Friedman
1982; Selby et al, 1988; Alexander et al, 1995; Corley et al, 2008).
The sera from the collections were stored at 23 1C or colder until
1980, when they were shipped to a frozen storage facility (40 1C) at
the Orentreich Foundation for the Advancement of Science,
25(OH)D levels in these stored sera have been shown to be stable
(Corder et al, 1993, 1995; Hiatt et al, 1998). Pathology records for
BCC diagnosis were from KPNC’s medical center in Oakland, CA,
which had computer-stored pathology records starting in 1974.
Ascertainment of cases and control selection
A total of 3,164 subjects with histologically confirmed BCCs
diagnosed between 1974 and 1989 have been previously identified
(Friedman and Tekawa, 2000). These individuals were identified by
examining pathology records classified using Systematized Nomen-
clature of Human and Veterinary Medicine codes (Cote, 1993). We
limited our time period for case selection to those individuals who
completed the MHCQ between 1968 and 1970 to minimize the time
interval between serum draw and BCC development. Power
calculations indicated that a sample size of 220 cases and 220
controls would result in a minimum detectable pattern of odds ratios
of 1.0, 1.21, 1.47, 1.78, and 2.16 for Q1 (quintile 1; referent), Q2,
Q3, Q4, and Q5, respectively, (test for trend, two-sided test;
a¼ 0.05; power¼ 0.80).
Our inclusion criteria for cases (n¼ 220) were: (1) ‘‘white’’ skin
color, as determined by MHC staff (categories of ‘‘yellow’’ and
‘‘brown’’ excluded), (2) previously unused serum sample associated
with a specific MHC visit between 1968 and 1970, (3) BCC
diagnosed based on Systematized Nomenclature of Human and
Veterinary Medicine morphology code between January 1974 and
31 December 1979 and (4) active KPNC membership each year
during the entire follow-up period.
Using incidence density sampling (Rothman and Greenwald,
1998) control subjects were matched 1:1 to cases by age (±1 year),
skin color (white), sex, eye color, date of serum collection (±1
month to control for seasonality), MHC location and length of KPNC
membership. All control subjects also had at least one unused serum
sample available for analysis with a specific MHC visit between
1968 and 1970 and had active KPNC membership each year during
the follow-up period. The study was approved by the Institutional
Review Board of KPNC and the Declaration of Helskinki protocols
were followed. The requirement for informed consent was waived.
Serum vitamin D levels
De-identified aliquoted frozen samples were sent from Orentreich
Foundation for the Advancement of Science (Cold Spring-on-
Hudson, New York) to Heartland Assays (Ames, IA) and analyzed
using the DiaSorin LIAISION 25(OH) Vitamin D Total Assay, which
includes 25(OH)D metabolites of vitamin D2 and D3 from plant and
animal foods, as well as that synthesized endogenously (Wagner
et al, 2009). Case and control specimens were handled in the same
standard manner, and laboratory personnel were blinded to case–-
control status. All assays were repeated for reliability. The
coefficients of variation for 25(OH)D samples were intra-assay
8.4% and inter-assay 11.4%.
We examined serum 25(OH)D levels as: (1) a continuous variable,
(2) a categorical variable divided into quintiles based on distribution
among controls, and (3) a categorical variable divided into clini-
cally accepted cutoffs (deficient: o10ngml–1; insufficient: 10 to
o30ngml–1, sufficient: X30ngml–1) (Kricker et al, 1995); http://
ods.od.nih.gov/factsheets/vitamind.asp, accessed 20 July 2009.
Covariates
All participants in the MHC had completed the MHCQ that included
information on age, education, current and past smoking behavior,
history of cancer, occupation, and occupational exposures. Informa-
tion on possible BCC risk factors was obtained from each subject’s
MHCQ and from information recorded by the MHC staff (height,
weight, eye color, skin color). When BMI data were missing from the
MHCQ administered on the serum draw date (n¼ 20), we imputed a
value based on the cohort mean value and included a missing data
flag in all models. When smoking information was missing, we
obtained smoking status from previous prediagnostic MHCQs, if
available. When data on education were missing, we used the
highest education level recorded among all available MHCQ,
hypothesizing that educational status would not have changed
significantly in the cohort between 1968 and 1970. We found
education level differences between questionnaires in only 2 cases
and 4 controls.
We analyzed four variables which served as surrogates of sun
exposure: time spent in leisure activities (ordered categorical
variable), time spent in exercise (ordered categorical variable),
previous occupational exposure to ultraviolet radiation (yes/no), and
occupational sun exposure derived from self-reported occupation
(categorical). For each reported occupation, we assigned a sun
exposure level (low, moderate, high) based on the standard duties of
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that occupation. Thus, for example, a mail carrier was deemed to
have high occupational sun exposure whereas an office clerk was
deemed to have low exposure. Sun exposure levels were reviewed
and agreed by the co-authors (MA, JT, MW, GF) and outside
investigators with relevant expertise.
Statistical analysis
Our overall analytic strategy was to: (1) compare baseline
characteristics of cases and controls (Table 1), (2) determine the
association between covariables and 25(OH)D levels in the entire
sample (Table 2), (3) examine the association between 25(OH)D
levels and BCC risk, controlling for identified confounding variables,
and (4) determine the association of serum 25(OH)D levels to BCC
risk, controlling for hypothesized potentially confounding variables.
We used conditional logistic regression to estimate odds ratios and
95% confidence intervals for BCC risk. We developed a multivariate
model that included only the variables associated with both
25(OH)D levels and BCC risk at the Po0.2 level; that is, BMI, and
smoking status (parsimonious multivariable model, model (1)). We
also developed a multivariate model in which all potentially
confounding variables were included (fully adjusted multivariate
model, model (2)). Tests for linear trend (1 d.f.) were conducted by
treating the ordered categorical values of the exposure categories as
continuous variables. Statistical analyses were performed using SAS,
version 9.1 (SAS Institute, Cary, NC).
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